Effects of the ultra-short-acting beta-blocker Esmolol infusion on cardiovascular parameters and quality of postoperative recovery in patients scheduled for elective plastic surgery
Background/Aim: Esmolol is an ultra-short-acting, easily titratable b-adrenergic receptor antagonist used for urgent treatment of hypertension and tachycardia in non-surgical and surgical settings. Aim of this clinical study was to investigate its cardiovascular effects and quality of the emergence...
Enregistré dans:
Auteur principal: | Lončar-Stojiljković Dragana |
---|---|
Format: | article |
Langue: | EN SR |
Publié: |
Medical Society of the Republic of Srpska, Banja Luka, University of Banja Luka. Faculty of Medicine
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/81ef032ae0c341a2b4a97b4e71a2b907 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Traumatic Refractory Ventricular Fibrillation Successfully Treated with Intra-Arrest Esmolol
par: Kevin Raymond, et autres
Publié: (2021) -
Comparative effects of lidocaine and esmolol in attenuating the hemodynamic response to laryngoscopy and intubation
par: Ram Bhakta Koju, et autres
Publié: (2017) -
Beta-blockers utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic
par: Milos Taborsky, et autres
Publié: (2021) -
Poor tolerance of beta-blockers by elderly patients with heart failure
par: Satoshi Yanagisawa, et autres
Publié: (2010) -
Current practice of thoracic anaesthesia in Europe – a survey by the European Society of Anaesthesiology Part I – airway management and regional anaesthesia techniques
par: Jerome Defosse, et autres
Publié: (2021)